M. Ugarte
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
M. Ugarte has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Begoña Merinero
Centro de Diagnóstico de Enfermedades Moleculares, Centro de Biología Molecular, Universidad Autónoma de Madrid, CIBERER, IdiPAZ, Madrid, Spain
4 shared publications - Celia Perez-Cerda
Centro de Diagnóstico de Enfermedades Moleculares, Centro de Biología Molecular, Universidad Autónoma de Madrid, CIBERER, IdiPAZ, Madrid, Spain
3 shared publications - Eva Richard
Centro de Biología Molecular Severo Ochoa UAM‐CSIC Universidad Autónoma de Madrid Madrid Spain
2 shared publications J A Del Valle
2 shared publicationsM J García
2 shared publicationsA Martinez Bermejo
1 shared publication
Latest Publications
- 10 October 2006
- p. S145-56
[Congenital disorders of glycosylation. Their diagnosis and treatment].
Glycosylation disorders are alterations in the biosynthesis of either N-glycoproteins, O-glycoproteins or both. Most of these diseases are multisystemic and lead to severe psychomotor retardation. Since Jaeken reported the first disorder in the N-glycosylation of proteins in the 1980s, our knowledge of clinical glycobiology has increased considerably. Thus, glycosylation disorders now include specific tissue diseases, such as disorders affecting cellular signalling that give rise to anomalous cell growth (cancer), disorders of leukocyte traffic and congenital muscular dystrophies associated to alterations in neuronal migration. All these diseases are the result of the presence of very specific anomalous glycans, which are often difficult to detect in physiological fluids and for which new diagnostic tools have to be developed. In this review, first, we outline the two most frequent routes for the glycosylation of proteins in humans, followed by a brief description of the associated genetic diseases and the diagnostic tools and therapies that are currently available. Every year new disorders are detected in the N- and O-glycosylation routes, and due to the fact that there are an estimated 500 genes involved in the synthesis or the functioning of glycoproteins, it would seem that, taken together, those that are currently known may well be just the 'tip of the iceberg'.
- 10 October 2006
- p. S145-56
[Congenital disorders of glycosylation. Their diagnosis and treatment].
Glycosylation disorders are alterations in the biosynthesis of either N-glycoproteins, O-glycoproteins or both. Most of these diseases are multisystemic and lead to severe psychomotor retardation. Since Jaeken reported the first disorder in the N-glycosylation of proteins in the 1980s, our knowledge of clinical glycobiology has increased considerably. Thus, glycosylation disorders now include specific tissue diseases, such as disorders affecting cellular signalling that give rise to anomalous cell growth (cancer), disorders of leukocyte traffic and congenital muscular dystrophies associated to alterations in neuronal migration. All these diseases are the result of the presence of very specific anomalous glycans, which are often difficult to detect in physiological fluids and for which new diagnostic tools have to be developed. In this review, first, we outline the two most frequent routes for the glycosylation of proteins in humans, followed by a brief description of the associated genetic diseases and the diagnostic tools and therapies that are currently available. Every year new disorders are detected in the N- and O-glycosylation routes, and due to the fact that there are an estimated 500 genes involved in the synthesis or the functioning of glycoproteins, it would seem that, taken together, those that are currently known may well be just the 'tip of the iceberg'.
- 20 September 2001
- Vol. 33 (2) , 101-11
[Bilateral hypodensity of the basal ganglia. Clinico-evolutionary correlation in children].
The presence in neuroimaging of areas of symmetrical bilateral hypodensity in the basal ganglia (SBHBG) is a striking and unusual finding. To determine the aetiology, clinical significance and evolution of a group of paediatric patients with SBHBG. We made a study of 21 patients with neuroimaging studies (CT or MR) showing SBHBG. The affected area was related to the aetiology, clinical features and evolution. The ages varied between 4 months and 16 years. In 7 cases Leigh s disease was diagnosed, 5 had had acute hypoxia, 4 type I glutaric aciduria, and 1 case each of methylmalonic aciduria, Ia gluconeogenesis, CO intoxication, acute striatal necrosis and bacterial meningitis. The putamen was affected in 6 cases, globus pallidus in 4 cases and the lenticular nucleus was damaged in the rest. Three cases also had lesions in the caudate nucleus. MR was better than CT for localization of the precise area involved. Clinically, 13 cases had extrapyramidal signs. We found no relation between the size, localization of the lesion and the prognosis, which was more dependent on the aetiology, only one patient (CO intoxication) recovered and eight died (Leigh s disease and 1 case of hypoxia). The presence of SBHBG in a patient makes extensive study necessary to find the aetiology. It is a nonspecific finding, usually of metabolic origin and with little correlation with the clinical condition. Its presence implies a poor prognosis and raises suspicion of the presence of certain neurological disorders.
- 20 September 2001
- Vol. 33 (2) , 101-11
[Bilateral hypodensity of the basal ganglia. Clinico-evolutionary correlation in children].
The presence in neuroimaging of areas of symmetrical bilateral hypodensity in the basal ganglia (SBHBG) is a striking and unusual finding. To determine the aetiology, clinical significance and evolution of a group of paediatric patients with SBHBG. We made a study of 21 patients with neuroimaging studies (CT or MR) showing SBHBG. The affected area was related to the aetiology, clinical features and evolution. The ages varied between 4 months and 16 years. In 7 cases Leigh s disease was diagnosed, 5 had had acute hypoxia, 4 type I glutaric aciduria, and 1 case each of methylmalonic aciduria, Ia gluconeogenesis, CO intoxication, acute striatal necrosis and bacterial meningitis. The putamen was affected in 6 cases, globus pallidus in 4 cases and the lenticular nucleus was damaged in the rest. Three cases also had lesions in the caudate nucleus. MR was better than CT for localization of the precise area involved. Clinically, 13 cases had extrapyramidal signs. We found no relation between the size, localization of the lesion and the prognosis, which was more dependent on the aetiology, only one patient (CO intoxication) recovered and eight died (Leigh s disease and 1 case of hypoxia). The presence of SBHBG in a patient makes extensive study necessary to find the aetiology. It is a nonspecific finding, usually of metabolic origin and with little correlation with the clinical condition. Its presence implies a poor prognosis and raises suspicion of the presence of certain neurological disorders.
- 1 September 2000
- Vol. 20 (9) , 761-4
Prenatal molecular diagnosis of glutaric aciduria type I by direct mutation analysis.
Various biochemical strategies are followed for the prenatal diagnosis of glutaric aciduria type I (GA I). However, since the description of patients with normal excretion of glutarate and significant residual activity, the difficulties of prenatal biochemical diagnosis are obvious. The characterization of the glutaryl-CoA dehydrogenase (GCDH) gene has allowed us to develop a single strand conformation polymorphism (SSCP) screening method, followed by direct sequencing, to identify the disease causing mutations in patients with GA I. Here we report the first prenatal diagnoses based on DNA analysis in chorionic villi biopsy or cultured amniotic fluid cells in three families at risk for GA I. Our results show that this strategy provides a fast and reliable method for prenatal diagnosis. In addition we report two new mutations (1209-1210ins G and R161W) in the GCDH gene that occurred at hypermutable loci.
- 1 September 2000
- Vol. 20 (9) , 761-4
Prenatal molecular diagnosis of glutaric aciduria type I by direct mutation analysis.
Various biochemical strategies are followed for the prenatal diagnosis of glutaric aciduria type I (GA I). However, since the description of patients with normal excretion of glutarate and significant residual activity, the difficulties of prenatal biochemical diagnosis are obvious. The characterization of the glutaryl-CoA dehydrogenase (GCDH) gene has allowed us to develop a single strand conformation polymorphism (SSCP) screening method, followed by direct sequencing, to identify the disease causing mutations in patients with GA I. Here we report the first prenatal diagnoses based on DNA analysis in chorionic villi biopsy or cultured amniotic fluid cells in three families at risk for GA I. Our results show that this strategy provides a fast and reliable method for prenatal diagnosis. In addition we report two new mutations (1209-1210ins G and R161W) in the GCDH gene that occurred at hypermutable loci.
- 1 September 1998
- Vol. 18 (9) , 947-52
Reliability of biochemical parameters used in prenatal diagnosis of combined methylmalonic aciduria and homocystinuria.
Prenatal diagnosis for combined methylmalonic aciduria and homocystinuria was performed in five at-risk pregnancies by determination of methylmalonic acid (MMA) and total homocysteine (Hcy) in amniotic fluid supernatant. The incorporation rate of [14C] propionate (+/- OHCbl) and the synthesis of cobalamin derivatives in cultured amniocytes were investigated as well as the [14C] MTHF incorporation rate in intact chorion biopsy. Our experience showed that total Hcy and MMA were clearly elevated in amniotic fluid of affected fetuses. Both the study of [14C] propionate incorporation and that of cobalamin synthesis in cultured amniocytes are useful to confirm the results of metabolite determination. The incorporation of [14C] MTHF in intact chorion biopsy seems not to be a reliable diagnostic method.
- 1 September 1998
- Vol. 18 (9) , 947-52
Reliability of biochemical parameters used in prenatal diagnosis of combined methylmalonic aciduria and homocystinuria.
Prenatal diagnosis for combined methylmalonic aciduria and homocystinuria was performed in five at-risk pregnancies by determination of methylmalonic acid (MMA) and total homocysteine (Hcy) in amniotic fluid supernatant. The incorporation rate of [14C] propionate (+/- OHCbl) and the synthesis of cobalamin derivatives in cultured amniocytes were investigated as well as the [14C] MTHF incorporation rate in intact chorion biopsy. Our experience showed that total Hcy and MMA were clearly elevated in amniotic fluid of affected fetuses. Both the study of [14C] propionate incorporation and that of cobalamin synthesis in cultured amniocytes are useful to confirm the results of metabolite determination. The incorporation of [14C] MTHF in intact chorion biopsy seems not to be a reliable diagnostic method.
- 29 June 1998
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 157 (1) , 50-52
An unusual late-onset case of propionic acidaemia: biochemical investigations, neuroradiological findings and mutation analysis.
- 29 June 1998
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 157 (1) , 50-52
An unusual late-onset case of propionic acidaemia: biochemical investigations, neuroradiological findings and mutation analysis.
- 8 October 1997
- Published by Springer Nature in Human Genetics
- Vol. 101 (1) , 93-96
Three novel splice mutations in the PCCA gene causing identical exon skipping in propionic acidemia patients
Propionyl-CoA carboxylase (PCC) is a mitochondrial, biotin-dependent enzyme involved in the catabolism of branched chain amino acids, odd chain fatty acids, and other metabolites. PCC consists of non-identical subunits, α and β, encoded by the PCCA and PCCB genes, respectively. Inherited deficiency of PCC due to mutations in either the PCCA or the PCCB gene results in propionic acidemia (PA), a clinically heterogeneous disorder with a severe, often lethal, neonatal form, and a mild, later onset form. To characterize PCCA gene mutations responsible for PCC deficiency, we analyzed RT-PCR products obtained from cultured fibroblasts from Spanish PCC-α deficient patients. In three patients, smaller than normal PCR products were observed, and sequence analysis revealed the deletion of a 54-bp exon in the cDNA. Sequencing of genomic DNA from these three patients led to the identification of three novel mutations in the PCCA gene, two short deletions and one small insertion, adjacent to short direct repeats, and all of them affecting the consensus splice sites of the skipped exon. These mutations, 1771IVS-2del9, 1824IVS+3del4, and 1824IVS+3insCT, are the cause of the aberrant splicing of the PCCA pre-mRNA and result in an in-frame deletion of 54 nucleotides in the cDNA, probably leading to an unstable protein structure which is responsible for the lack of activity leading to PCC deficiency in these patients.
- 8 October 1997
- Published by Springer Nature in Human Genetics
- Vol. 101 (1) , 93-96
Three novel splice mutations in the PCCA gene causing identical exon skipping in propionic acidemia patients
Propionyl-CoA carboxylase (PCC) is a mitochondrial, biotin-dependent enzyme involved in the catabolism of branched chain amino acids, odd chain fatty acids, and other metabolites. PCC consists of non-identical subunits, α and β, encoded by the PCCA and PCCB genes, respectively. Inherited deficiency of PCC due to mutations in either the PCCA or the PCCB gene results in propionic acidemia (PA), a clinically heterogeneous disorder with a severe, often lethal, neonatal form, and a mild, later onset form. To characterize PCCA gene mutations responsible for PCC deficiency, we analyzed RT-PCR products obtained from cultured fibroblasts from Spanish PCC-α deficient patients. In three patients, smaller than normal PCR products were observed, and sequence analysis revealed the deletion of a 54-bp exon in the cDNA. Sequencing of genomic DNA from these three patients led to the identification of three novel mutations in the PCCA gene, two short deletions and one small insertion, adjacent to short direct repeats, and all of them affecting the consensus splice sites of the skipped exon. These mutations, 1771IVS-2del9, 1824IVS+3del4, and 1824IVS+3insCT, are the cause of the aberrant splicing of the PCCA pre-mRNA and result in an in-frame deletion of 54 nucleotides in the cDNA, probably leading to an unstable protein structure which is responsible for the lack of activity leading to PCC deficiency in these patients.
- 1 January 1995
- Vol. 26 (1) , 53-7
Molecular analysis of the phenylalanine hydroxylase gene in Mexican phenylketonuric patients.
The molecular analysis of the human phenylalanine hydroxylase (PAH) gene in Mexican phenylketonuric (PKU) patients is described. We analyzed the restriction fragment length polymorphism (RFLP) haplotypes of five probands and ten non-affected relatives, belonging to four unrelated PKU families. Twenty-nine alleles were typified, corresponding to 12 different haplotypes. Eight RFLP haplotypes corresponded to those described in other populations, while the remaining were unreported haplotypes, appearing both on normal and PKU chromosomes. Using the polymerase chain reaction (PCR) and the allele-specific oligonucleotide assay (ASO), we also screened for the IVS10 mutation, one of the most common PAH gene mutations in Mediterranean countries. Forty-two percent of the PKU chromosomes analyzed bore the IVS10 mutation, although it was present in the heterozygous state in all cases. Our data show an important genetic heterogeneity at the PAH locus in the Mexican population, and report the genetic influence of the Spanish immigration to the American continent.
- 1 January 1995
- Vol. 26 (1) , 53-7
Molecular analysis of the phenylalanine hydroxylase gene in Mexican phenylketonuric patients.
The molecular analysis of the human phenylalanine hydroxylase (PAH) gene in Mexican phenylketonuric (PKU) patients is described. We analyzed the restriction fragment length polymorphism (RFLP) haplotypes of five probands and ten non-affected relatives, belonging to four unrelated PKU families. Twenty-nine alleles were typified, corresponding to 12 different haplotypes. Eight RFLP haplotypes corresponded to those described in other populations, while the remaining were unreported haplotypes, appearing both on normal and PKU chromosomes. Using the polymerase chain reaction (PCR) and the allele-specific oligonucleotide assay (ASO), we also screened for the IVS10 mutation, one of the most common PAH gene mutations in Mediterranean countries. Forty-two percent of the PKU chromosomes analyzed bore the IVS10 mutation, although it was present in the heterozygous state in all cases. Our data show an important genetic heterogeneity at the PAH locus in the Mexican population, and report the genetic influence of the Spanish immigration to the American continent.
- 1 May 1982
- Vol. 16 (5) , 416-20
[Neonatal hyperammonemia due to ornithine transcarbamylase deficiency (author's transl)].
The clinical and biochemical findings in a patient with the inherited disease so called hyperammonemia type II are presented. The patient was a male who had the first abnormal symptoms of tremors and continuous crying at 35 hours of age and exhibited a rapid clinical course dying 62 hours after birth. Rejection of food, respiratory problems, hypotonia and tonic-clonic convulsions were other outstanding clinical symptoms observed. Withdrawal of the feedings and initiation of a perfusion did not improve the clinical picture. Biochemical studies in samples of blood, urine and CSF revealed the presence of high concentrations of ammonia, alanine, glutamine and orotic acid. Final diagnosis was achieved when post mortem liver ornithine transcarbamylase activity was found to be lower than 6% with respect to that of adequate controls. Carbamyl phosphate synthetase, another urea cycle enzyme measured, was within normal limits of activity.
- 1 May 1982
- Vol. 16 (5) , 416-20
[Neonatal hyperammonemia due to ornithine transcarbamylase deficiency (author's transl)].
The clinical and biochemical findings in a patient with the inherited disease so called hyperammonemia type II are presented. The patient was a male who had the first abnormal symptoms of tremors and continuous crying at 35 hours of age and exhibited a rapid clinical course dying 62 hours after birth. Rejection of food, respiratory problems, hypotonia and tonic-clonic convulsions were other outstanding clinical symptoms observed. Withdrawal of the feedings and initiation of a perfusion did not improve the clinical picture. Biochemical studies in samples of blood, urine and CSF revealed the presence of high concentrations of ammonia, alanine, glutamine and orotic acid. Final diagnosis was achieved when post mortem liver ornithine transcarbamylase activity was found to be lower than 6% with respect to that of adequate controls. Carbamyl phosphate synthetase, another urea cycle enzyme measured, was within normal limits of activity.
- 1 January 1982
- p. 207-10
[Human fibroblast bank for studying amino acid disorders and organic acidemias].
The establishment of a fibroblast bank from patients with biochemical alterations in the metabolism of aminoacids and organic acids has been initiated. The patients suffered from distinct variants of maple syrup urine disease, propionic acidaemia, methylmalonic acidaemia, lactic acidosis and hyperglycinuria. Thirty six human cell lines corresponding to patients with these diseases, their relatives and control individuals have been accumulated.
- 1 January 1982
- p. 207-10
[Human fibroblast bank for studying amino acid disorders and organic acidemias].
The establishment of a fibroblast bank from patients with biochemical alterations in the metabolism of aminoacids and organic acids has been initiated. The patients suffered from distinct variants of maple syrup urine disease, propionic acidaemia, methylmalonic acidaemia, lactic acidosis and hyperglycinuria. Thirty six human cell lines corresponding to patients with these diseases, their relatives and control individuals have been accumulated.